370P Bespoke circulating tumour DNA assay for the detection of minimal residual disease in esophageal adenocarcinoma patients

Annals of Oncology ◽

10.1016/j.annonc.2020.10.594 ◽

2020 ◽

Vol 31 ◽

pp. S1317-S1318

Author(s):

E. Ococks ◽

A. Ng ◽

G. Devonshire ◽

S. Dashner ◽

W-C. Chan ◽

...

Keyword(s):

Minimal Residual Disease ◽

Esophageal Adenocarcinoma ◽

Residual Disease ◽

Dna Assay ◽

Circulating Tumour Dna ◽

Minimal Residual

Download Full-text

81MO Clinical experience of a personalized and tumour-informed circulating tumour DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients

Annals of Oncology ◽

10.1016/j.annonc.2020.10.101 ◽

2020 ◽

Vol 31 ◽

pp. S1274

Author(s):

S.A. Cohen ◽

N. Hook ◽

S. Krinshpun ◽

L. Westbrook ◽

K. Loranger ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Minimal Residual Disease ◽

Clinical Experience ◽

Residual Disease ◽

Disease Detection ◽

Dna Assay ◽

Colorectal Cancer Patients ◽

Circulating Tumour Dna ◽

Minimal Residual

Download Full-text

405MO Personalized circulating tumour DNA assay for the detection of minimal residual disease in CRC patients after resection of metastases

Annals of Oncology ◽

10.1016/j.annonc.2020.08.516 ◽

2020 ◽

Vol 31 ◽

pp. S413

Author(s):

F. Loupakis ◽

M. Derouazi ◽

S. Murgioni ◽

M.D. Rizzato ◽

S. Sharma ◽

...

Keyword(s):

Minimal Residual Disease ◽

Residual Disease ◽

Dna Assay ◽

Resection Of Metastases ◽

Circulating Tumour Dna ◽

Minimal Residual

Download Full-text

Circulating Tumour DNA for Detecting Minimal Residual Disease in Multiple Myeloma

Seminars in Hematology ◽

10.1053/j.seminhematol.2018.03.002 ◽

2018 ◽

Vol 55 (1) ◽

pp. 38-40 ◽

Author(s):

Trevor J. Pugh

Keyword(s):

Multiple Myeloma ◽

Minimal Residual Disease ◽

Residual Disease ◽

Circulating Tumour Dna ◽

Minimal Residual

Download Full-text

SO-34 Clinical experience of a personalized and tumor-informed circulating tumor DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients

Annals of Oncology ◽

10.1016/j.annonc.2020.04.049 ◽

2020 ◽

Vol 31 ◽

pp. S229

Author(s):

S. Cohen ◽

N. Hook ◽

S. Krinshpun ◽

L. Westbrook ◽

K. Loranger ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Minimal Residual Disease ◽

Clinical Experience ◽

Residual Disease ◽

Circulating Tumor Dna ◽

Dna Assay ◽

Colorectal Cancer Patients ◽

Tumor Dna ◽

Minimal Residual

Download Full-text

Minimal Residual Disease Detection using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-21-0410 ◽

2021 ◽

pp. clincanres.0410.2021

Author(s):

Aparna R. Parikh ◽

Emily E. Van Seventer ◽

Giulia Siravegna ◽

Anna V Hartwig ◽

Ariel Jaimovich ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Minimal Residual Disease ◽

Residual Disease ◽

Circulating Tumor Dna ◽

Disease Detection ◽

Dna Assay ◽

Colorectal Cancer Patients ◽

Tumor Dna ◽

Minimal Residual

Download Full-text

Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype

Annals of Oncology ◽

10.1093/annonc/mdz246 ◽

2019 ◽

Vol 30 ◽

pp. v198 ◽

Author(s):

N Tarazona Llavero ◽

F. Gimeno-Valiente ◽

V. Gambardella ◽

M. Huerta ◽

S Rosello Keranen ◽

...

Keyword(s):

Colorectal Cancer ◽

High Risk ◽

Minimal Residual Disease ◽

Residual Disease ◽

Risk Of Recurrence ◽

Cdx2 Expression ◽

Circulating Tumour Dna ◽

Minimal Residual

Download Full-text

Decision letter for "MINIMAL RESIDUAL DISEASE (MRD) IN NON‐HODGKIN LYMPHOMAS: INTER‐LABORATORY REPRODUCIBILITY ON MARROW SAMPLES WITH VERY LOW LEVELS OF DISEASE WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK"

10.1002/hon.2652/v2/decision1 ◽

2019 ◽

Keyword(s):

Minimal Residual Disease ◽

Residual Disease ◽

Minimal Residual

Download Full-text

Review for "MINIMAL RESIDUAL DISEASE (MRD) IN NON‐HODGKIN LYMPHOMAS: INTER‐LABORATORY REPRODUCIBILITY ON MARROW SAMPLES WITH VERY LOW LEVELS OF DISEASE WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK"

10.1002/hon.2652/v1/review1 ◽

2019 ◽

Keyword(s):

Minimal Residual Disease ◽

Residual Disease ◽

Minimal Residual

Download Full-text

ACUTE LEUKEMIAS 2019: Risikofaktor MRD eröffnet neue Perspektiven

Onkologische Welt ◽

10.1055/a-0903-8595 ◽

2019 ◽

Vol 10 (04) ◽

pp. 158-160

Author(s):

Ulrike Röper

Keyword(s):

Minimal Residual Disease ◽

Residual Disease ◽

Individualisierte Therapie ◽

Acute Leukemias ◽

Minimal Residual

Weiterentwicklungen in der Molekulardiagnostik ermöglichen zuverlässigere Aussagen zur Differenzialdiagnostik maligner Erkrankungen. Sie sind Meilensteine für eine individualisierte Therapie. Darüber hinaus zeigt sich ihre zunehmende Bedeutung für prognostische Einschätzungen. Die Kontrolle der minimalen Resterkrankung (Minimal Residual Disease; MRD) rückt zunehmend in den Fokus, auch wenn noch viele Fragen zu klären sind.

Download Full-text

A mathematical approach to data evaluation with focus on prediction of minimal residual disease in pediatric ALL

Klinische Pädiatrie ◽

10.1055/s-0032-1310472 ◽

2012 ◽

Vol 224 (03) ◽

Author(s):

A Torge ◽

M Zimmermann ◽

A Möricke ◽

R Köhler ◽

A Schrauder ◽

...

Keyword(s):

Minimal Residual Disease ◽

Residual Disease ◽

Data Evaluation ◽

Mathematical Approach ◽

Pediatric All ◽

Minimal Residual

Download Full-text